UNRESECTABLE MERKEL CELL CARCINOMA
Clinical trials for UNRESECTABLE MERKEL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE MERKEL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Balancing act: fighting cancer while protecting a transplanted kidney
Disease control OngoingThis early-phase study is testing a combination of immunotherapy drugs (nivolumab and ipilimumab) along with standard transplant medications (tacrolimus and prednisone) in kidney transplant patients with advanced skin cancers that have spread or cannot be removed by surgery. The …
Matched conditions: UNRESECTABLE MERKEL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo tested for Tough-to-Treat skin cancer
Disease control OngoingThis study is for people with advanced Merkel cell carcinoma, a rare and aggressive skin cancer, that has worsened despite prior immunotherapy. It is testing whether a new oral drug called tuvusertib, which targets cancer cell DNA repair, works better alone or when combined with …
Matched conditions: UNRESECTABLE MERKEL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC